ليوكوسيل 2 لقاح لوكيميا القطط المعطل
Leukocell 2 is an inactivated feline leukemia virus (FeLV) vaccine prepared from cell-free culture fluids of transformed lymphoid cells, containing gp70 envelope antigens, p15E, and FOCMA (feline oncornavirus-associated cell membrane antigen). Indicated for vaccination of healthy cats 9 weeks of age or older as an aid in preventing persistent FeLV viremia, lymphoid tumors, and mortality caused by feline leukemia virus.
Dosage Form
Injection
Product Type
Biological
Manufacturer
Package
Cartons of 25 x 1-dose liquid vials (1 mL each)
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Cat | 1 mL administered subcutaneously | Subcutaneous (SC) | Initial series of 2 doses administered 3 to 4 weeks apart; revaccinate annually |
No withdrawal information available.
Vaccination of healthy cats 9 weeks of age or older as an aid in preventing feline leukemia virus infection, persistent viremia, and FeLV-related tumors.
Cats should be tested for FeLV antigen prior to vaccination; vaccination of viremic cats is not beneficial.
Anaphylactic reactions may occur; administer epinephrine immediately if required.
Transient local swelling or granuloma at the injection site, transient pyrexia.
Leukocell 2 Feline Leukemia Vaccine Prescribing Information
LeafletNo diseases linked.
No data available
Information has not been added yet.
No data available
Information has not been added yet.
Manufacturer
No alternatives available.